Drug Monitoring

"Drug Monitoring" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.

Descriptor ID	D016903
MeSH Number(s)	E01.370.520.200
Concept/Terms	Drug Monitoring Drug Monitoring Monitoring, Drug Therapeutic Drug Monitoring Therapeutic Drug Monitoring Drug Monitoring, Therapeutic Monitoring, Therapeutic Drug

Below are MeSH descriptors whose meaning is more general than "Drug Monitoring".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Diagnosis [E01]
Diagnostic Techniques and Procedures [E01.370]
Monitoring, Physiologic [E01.370.520]
Drug Monitoring [E01.370.520.200]

Below are MeSH descriptors whose meaning is related to "Drug Monitoring".

Below are MeSH descriptors whose meaning is more specific than "Drug Monitoring".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Drug Monitoring" by people in this website by year, and whether "Drug Monitoring" was a major or minor topic of these publications.

Bar chart showing 55 publications over 19 distinct years, with a maximum of 5 publications in 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	0	2	2
2003	2	2	4
2004	1	1	2
2005	2	0	2
2006	0	4	4
2007	2	1	3
2008	3	1	4
2009	1	2	3
2010	0	2	2
2011	0	4	4
2012	2	2	4
2013	1	1	2
2014	2	1	3
2015	1	2	3
2016	0	1	1
2017	1	2	3
2019	1	1	2
2020	4	1	5
2021	1	1	2

Below are the most recent publications written about "Drug Monitoring" by people in Profiles.

Jimbo M, Andrews JR, Ahmed ME, Dundar A, Karnes RJ, Bryce AH, Kendi AT, Kwon ED, Lowe VJ, Bold MS. Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy. Prostate. 2022 01; 82(1):41-48.

View in: PubMed
Conti RM, Padula WV, Becker RV, Salamone S. The cost-effectiveness of therapeutic drug monitoring for the prescription drug-based treatment of chronic myeloid leukemia. J Manag Care Spec Pharm. 2021 Aug; 27(8):1077-1085.

View in: PubMed
Hampson AJ, Schroeder JR, Ellefsen KN, Yammine L, Epstein DH, Preston KL, Huestis MA, Verrico CD. Subtherapeutic Acetazolamide Doses as a Noninvasive Method for Assessing Medication Adherence. Clin Pharmacol Ther. 2020 12; 108(6):1203-1212.

View in: PubMed
Di Trana A, La Maida N, Tittarelli R, Huestis MA, Pichini S, Busard? FP, Carlier J. Monitoring Prenatal Exposure to Buprenorphine and Methadone. Ther Drug Monit. 2020 04; 42(2):181-193.

View in: PubMed
Carlier J, La Maida N, Di Trana A, Huestis MA, Pichini S, Busard? FP. Testing Unconventional Matrices to Monitor for Prenatal Exposure to Heroin, Cocaine, Amphetamines, Synthetic Cathinones, and Synthetic Opioids. Ther Drug Monit. 2020 04; 42(2):205-221.

View in: PubMed
Carlier J, Huestis MA, Zaami S, Pichini S, Busard? FP. Monitoring Perinatal Exposure to Cannabis and Synthetic Cannabinoids. Ther Drug Monit. 2020 04; 42(2):194-204.

View in: PubMed
McEvoy JP, Kremens DE. Early Recognition and Treatment of Tardive Dyskinesia in Patients With Mood Disorders and Schizophrenia. J Clin Psychiatry. 2020 Jan 28; 81(1).

View in: PubMed
Hozack BA, Rivlin M, Graham J, Lutsky KF, Beredjiklian PK. Validation of the prescription drug monitoring program Web site. J Opioid Manag. 2019 Nov/Dec; 15(6):495-498.

View in: PubMed
Pokorney SD, Holmes DN, Thomas L, Fonarow GC, Kowey PR, Reiffel JA, Singer DE, Freeman JV, Gersh BJ, Mahaffey KW, Hylek EM, Naccarelli GV, Ezekowitz MD, Piccini JP, Peterson ED. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation. JAMA Cardiol. 2019 08 01; 4(8):756-764.

View in: PubMed
Hertz DL, Speth KA, Kidwell KM, Gersch CL, Desta Z, Storniolo AM, Stearns V, Skaar TC, Hayes DF, Henry NL, Rae JM. Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast Cancer Res Treat. 2017 Oct; 165(3):659-668.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement